Burckhardt Compression Holding AG
XBER:B5H
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Burckhardt Compression Holding AG
XBER:B5H
|
CH |
|
A
|
Ageas SA
LSE:0Q99
|
BE |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
Q
|
Quest Diagnostics Inc
F:QDI
|
US |
|
P
|
Pfizer Inc
DUS:PFE
|
US |
|
Ageas SA
MIL:1AGS
|
BE |
|
I
|
ITV PLC
DUS:IJ7
|
UK |
|
B
|
Barrick Gold Corp
F:ABR
|
CA |
|
S
|
Scor SE
LSE:0IT3
|
FR |
Wall St Price Targets
B5H Price Targets Summary
Burckhardt Compression Holding AG
According to Wall Street analysts, the average 1-year price target for B5H is 306.68 EUR with a low forecast of 249.84 EUR and a high forecast of 352.85 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is B5H's stock price target?
Price Target
306.68
EUR
According to Wall Street analysts, the average 1-year price target for B5H is 306.68 EUR with a low forecast of 249.84 EUR and a high forecast of 352.85 EUR.
What is the Revenue forecast for Burckhardt Compression Holding AG?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 7 years is 3%.
What is the Operating Income forecast for Burckhardt Compression Holding AG?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 7 years is 3%.
What is the Net Income forecast for Burckhardt Compression Holding AG?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 4%.
